Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
about
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaThe evolution of poxvirus vaccinesThe March Toward Malaria VaccinesHuman vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaAnalysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag-pol-nef antigenControlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming.Progress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".Recent advances in recombinant protein-based malaria vaccines.Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection.Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.The march toward malaria vaccines.Recombinant modified vaccinia virus Ankara-based malaria vaccines.Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.Development of replication-deficient adenovirus malaria vaccines.HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients.Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Controlled Human Malaria Infection: Applications, Advances and Challenges.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?Development of an adenovirus vector vaccine platform for targeting dendritic cells.Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.Simian adenoviruses as vaccine vectors.
P2860
Q24273364-3BA86F07-227B-4250-A81D-0C12A558446AQ26772878-8754BDBA-CB1E-4594-B869-6D38095834B1Q26995905-FADA3FE6-2BD4-49CA-B6CD-B776CB4CBCF4Q28084325-CEC5D343-7DB9-4A60-BFF9-FADF7CC389FEQ33798074-AEC4B59F-7D14-4761-A0BE-F5B7533124F4Q35557657-C7606C62-231D-428A-8C88-F24CA58D2748Q36064542-709697D3-5B72-4764-B037-CE4E4CC97D2FQ36369321-B6A4575E-CB39-4985-AD73-2381D05393A0Q36389006-01B133AB-77FF-43C4-AC99-ECBE9D517FC2Q36394177-B6D1A0E7-312A-4A86-A51A-1949EEE4A854Q36394182-EE2DB62D-3C17-407E-BED0-2CF099D080C8Q36871970-E563BF43-C6B1-4B6E-AD50-1CD7D9E6B89AQ37334935-06F57E09-6AA8-486B-A17C-4ADB37CDC4F6Q37350955-B022890D-6020-4D68-97DC-7220B5AE30BEQ38577638-D400A99B-595E-49EB-9A65-74192011E63BQ38618898-DFF9BB77-6CCB-4608-AD6D-CF6BB21B0D2AQ38762695-DFE1361A-1550-4385-A948-5C04761CDE57Q38949194-BDFCCEE3-D966-4FB1-BB0B-59466F2E1FE4Q40089181-DA94AC43-C772-4717-8E0D-391A67E1CF94Q40638270-C86D142F-D8B3-4464-B708-2944CE074374Q41699782-EB04F0CA-CC76-4E24-850E-1946B549256DQ44168331-3FE7CA1E-EA33-405C-89CF-6C225FDEE9A2Q45325213-CEEE2BDD-5F1F-4881-8500-28C43FDF1DFBQ47248134-FF6FEC78-7051-43DE-B59A-E6CBE87FD141Q47576664-4597CF99-2884-4107-8FCF-2632CBD53DBFQ54531277-8E7E67A6-07B8-4901-94E5-19DC48D26B86
P2860
Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Assessment of humoral immune r ...... infection and natural exposure
@ast
Assessment of humoral immune r ...... infection and natural exposure
@en
Assessment of humoral immune r ...... infection and natural exposure
@nl
type
label
Assessment of humoral immune r ...... infection and natural exposure
@ast
Assessment of humoral immune r ...... infection and natural exposure
@en
Assessment of humoral immune r ...... infection and natural exposure
@nl
prefLabel
Assessment of humoral immune r ...... infection and natural exposure
@ast
Assessment of humoral immune r ...... infection and natural exposure
@en
Assessment of humoral immune r ...... infection and natural exposure
@nl
P2093
P2860
P50
P1433
P1476
Assessment of humoral immune r ...... infection and natural exposure
@en
P2093
Christopher J A Duncan
Geraldine A O'Hara
Kathryn H Milne
Katie J Ewer
Prateek Choudhary
Sean C Elias
Simone C de Cassan
Sumi Biswas
P2860
P304
P356
10.1371/JOURNAL.PONE.0107903
P407
P50
P577
2014-09-25T00:00:00Z